Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the execution of an oncology-focused mutational analysis services agreement with Bayer Schering Pharma AG, Germany
Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis, and Bayer...
Prometheus and Bayer Schering Pharma to Apply Novel Diagnostic Platform to Oncology Therapeutic CandidatesMarch 17, 2010 5:07 am | News | Comments
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has announced the...
CHADDS FORD, Pa. (AP) — The FDA has extended a review of a testosterone drug candidate by three...
NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Wednesday a U.S. Court backed a ruling that overturned a patent behind Bayer Schering's birth control pill Yasmin. Teva said the U.S. Court of Appeals for the Federal Circuit supported an earlier ruling made by the U.S.
FRANKFURT (AP) — German pharmaceutical company Bayer AG said Thursday it will invest euro100 million ($129 million) in a new global research and development center in Beijing over the next five years.
Barr Pharmaceuticals, Inc. recently announced that its subsidiary, Barr Laboratories, Inc., has
Bayer HealthCare has announced a structural realignment of its global pharmaceutical research and development organization. The company also outlined its future U.S. pharma site plan, and said that New Jersey will be home to its U.S. headquarters for pharmaceuticals.